Bat Ecologist Thomas Kunz Dies

The Boston University professor, who died of complications related to COVID-19, spent more than 40 years researching the lives of bats.

Written byClaire Jarvis
| 2 min read
thomas kunz boston university mammalogy mammalogists bats ecology covid-19 coronavirus pandemic obituary

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Thomas Kunz, a mammalogist at Boston University who studied and advocated for bats, died April 13 from complications associated with COVID-19. He was 81.

Kunz was born in Independence, Missouri, on June 11, 1938. He received a bachelor’s in biology in 1961 and master’s in education in 1962 from Central Missouri State College. He went on to receive a master’s from Drake University in biology in 1968.

After earning a PhD from the University of Kansas in systematics and ecology in 1971, Kunz joined the faculty in the Department of Biology at Boston University. He remained there until 2011, when injuries from a car accident forced him to retire from academic duties.

Kunz studied the ecology and population dynamics of bats in the United States, Costa Rica, Ecuador, Trinidad, India, and Malaysia. He used thermal infrared imaging to count bats in colonies and track flight patterns.

A popular figure on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • claire jarvis

    Claire Jarvis a science and medical writer based in Atlanta who contributes to The Scientist. With a research background in chemistry, she has covered the latest scientific and medical advances for Chemical & Engineering NewsChemistry WorldUndarkPhysics Today, and OneZero.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies